DMAC Chart
See on advanced chart >
About
Diamedica Therapeutics Inc. was initially incorporated pursuant to The Corporations Act (Manitoba) by articles of incorporation dated January 21, 2000. On May 31, 2019, to continue existence from a corporation incorporated under the CBCA into British Columbia...
Read More
- HighlightA clinical-stage biopharmaceutical company focused on developing novel recombinant protein therapeutics for the treatment of acute ischemic stroke and chronic kidney disease
- ExchangeNASDAQ
- Listing Date12/07/2018
- Established Date01/21/2000
- Full-time Employees18
- Address301 Carlson Parkway Suite 210 Minneapolis Minnesota 55305
- Tel1-763-4965454
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology